Alchemab Therapeutics Announces Largest Ever Life Sciences Investment From British Business Bank to Advance AI-Enabled Clinical Pipeline of Next Generation Human-Derived Antibodies

CAMBRIDGE, England--(BUSINESS WIRE)--Alchemab Therapeutics has secured £25m/$34m from the British Business Bank – the Bank’s largest investment in a life sciences company to date.